Ardent Health appoints Robert A. DeMichiei to board; former UPMC CFO

Ardent Health, Inc.

Board expanded to 11 members; DeMichiei fills newly created seat effective April 2, 2025.
DeMichiei served as EVP and CFO of UPMC (2004–2020), driving financial growth and M&A.
Will serve on Audit & Compliance Committee and Nominating & Corporate Governance Committee.
Also serves on boards of Waystar (WAY), Ampco-Pittsburgh (AP), and as advisor to Health Catalyst (HCAT).
Over 30 years of finance and healthcare leadership, including roles at GE and PwC.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert A. DeMichiei

director

ARDT · Ardent Health, Inc.

Effective: 2025-04-02
Filed: April 3, 2025, 7:59 PM ET

it has increased the size of the Company’s Board of Directors (the "Board") to 11 members and has appointed Robert A. DeMichiei to fill the newly created seat on the Board, effective April 2, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert A. DeMichiei was appointed as director at Ardent Health, Inc..

Action: appointed
Role: director

Exact text from the filing

it has increased the size of the Company’s Board of Directors (the "Board") to 11 members and has appointed Robert A. DeMichiei to fill the newly created seat on the Board, effective April 2, 2025.

View on SEC.gov

Ardent Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-016620

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.